# Torrent Pharmaceuticals Limited clinical trials: 72 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 72 trials with Torrent Pharmaceuticals Limited as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Torrent Pharmaceuticals Limited: 72 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/torrent-pharmaceuticals-limited

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 72
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 72, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 11, 2020 | NCT04507347 | Efficacy and Safety of TRC041266 in Patients With Heart Failure, LVEF ≥40%, Diastolic Dysfunction and Type 2 Diabetes Mellitus | Torrent Pharmaceuticals Limited | Phase 3 | Withdrawn | Chronic Stable Heart Failure | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04507347) |
| July 11, 2019 | NCT04015375 | Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris | Torrent Pharmaceuticals Limited | Phase 3 | Completed | Acne Vulgaris | 1,150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04015375) |
| May 7, 2018 | NCT03517033 | Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy Subjects | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03517033) |
| May 7, 2018 | NCT03517020 | Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy Subjects | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03517020) |
| October 24, 2017 | NCT03319706 | Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablets Under Fed Conditions | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy Subjects | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03319706) |
| October 23, 2017 | NCT03318354 | Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablet Under Fasting Conditions | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy Subjects | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03318354) |
| August 18, 2017 | NCT03254446 | Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension | Torrent Pharmaceuticals Limited | Phase 3 | Unknown | Diabetes, Dyslipidemias, Hypertension | 1,250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03254446) |
| November 16, 2016 | NCT02965274 | Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablets Under Fed Conditions | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy Subjects | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02965274) |
| November 16, 2016 | NCT02965261 | Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablet Under Fasting Conditions | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy Subjects | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02965261) |
| November 11, 2016 | NCT02962336 | Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions. | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy Subjects | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02962336) |
| November 11, 2016 | NCT02962323 | Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy Subjects | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02962323) |
| November 11, 2016 | NCT02962310 | Bio Equivalence Study of Torrent Pharmaceutical Ltd's Rosuvastatin Calcium Tablets Under Fasting Condition. | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy Subjects | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02962310) |
| November 11, 2016 | NCT02962258 | BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy Subjects | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02962258) |
| February 11, 2016 | NCT02680132 | Bioequivalence Study of Torrent Pharmaceutical Ltd's Esomeprazole Magnesium Delayed Release Capsules | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02680132) |
| February 11, 2016 | NCT02680119 | BE of Torrent's Esomeprazole Mg DR Capsules | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02680119) |
| January 20, 2016 | NCT02659683 | Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Esomeprazole Magnesium DR Capsules Under Fasting Conditions | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy Subjects | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02659683) |
| November 27, 2013 | NCT01996501 | Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fed Condition | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01996501) |
| November 27, 2013 | NCT01996488 | Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fasting Condition | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01996488) |
| November 27, 2013 | NCT01996475 | Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fed Condition | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01996475) |
| November 27, 2013 | NCT01996462 | Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fasting Condition | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01996462) |
| November 21, 2013 | NCT01990586 | Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Rabeprazole Sodium Delayed Release Tablets Under Fed Conditions | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01990586) |
| November 21, 2013 | NCT01990378 | Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Rabeprazole Sodium Delayed Release Tablets Under Fasted Conditions | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01990378) |
| August 29, 2013 | NCT01931514 | Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium Chewable 5mg Tablet Under Fed Conditions | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01931514) |
| August 29, 2013 | NCT01931501 | Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium Chewable Tablets 5mg Under Fasted Conditions | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01931501) |
| August 23, 2013 | NCT01928069 | Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium 10mg Tablet Under Fed Conditions | Torrent Pharmaceuticals Limited | Phase 1 | Completed | Healthy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01928069) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 68 |
| Phase 1/2 | 1 |
| Phase 3 | 3 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 70 |
| Withdrawn | 1 |
| Unknown | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetes Mellitus, Type 2 | 4 |
| Schizophrenia | 1 |
| Metabolic Syndrome | 1 |
| Insulin Resistance | 1 |
| Acne Vulgaris | 1 |
| Diabetes Mellitus | 1 |
| Dyslipidemias | 1 |
| Hypertension | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pharmaceutical companies in the United States](https://specstream.ai/data/businesses/pharmaceutical-companies/united-states)
- [Paving contractors in the United States](https://specstream.ai/data/businesses/paving-contractors/united-states)
- [Osteopathic practices in the United States](https://specstream.ai/data/businesses/osteopathic-practices/united-states)
- [Obstetrics and gynecology practices in the United States](https://specstream.ai/data/businesses/obstetrics-and-gynecology-practices/united-states)
- [Mortgage lenders in the United States](https://specstream.ai/data/businesses/mortgage-lenders/united-states)
- [Mediterranean restaurants in the United States](https://specstream.ai/data/businesses/mediterranean-restaurants/united-states)
